Radiation boost tested to extend life of revolutionary cancer therapy

NCT ID NCT05336383

Summary

This study is testing whether adding radiation therapy can improve outcomes for patients with multiple myeloma whose cancer has returned after receiving CAR-T cell therapy. The research will enroll 30 adults who still show active disease on scans at least 30 days after their CAR-T treatment. Doctors will deliver targeted radiation to up to five tumor sites to see if this combination approach is safe and helps control the cancer longer.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • M D Anderson Cancer Center

    RECRUITING

    Houston, Texas, 77030, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.